Appendix 2—table 44. Antidepressant User Cohort (All Regions) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| All Antidepressant Users by BP: Unmatched | All Antidepressant Users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 1,536,048 | 100.0% | 1,390,939 | 90.6% | 145,109 | 9.4% | 288,564 | 100.0% | 144,282 | 50.0% | 144,282 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 89,571 | 5.8% | 89,415 | 6.4% | 156 | 0.1% | <0.001 | 313 | 0.1% | 157 | 0.1% | 156 | 0.1% | 1.00 |
| 21-40 | 315,593 | 20.5% | 314,429 | 22.6% | 1,164 | 0.8% | 2,326 | 0.8% | 1,162 | 0.8% | 1,164 | 0.8% | ||
| 41-50 | 233,345 | 15.2% | 229,878 | 16.5% | 3,467 | 2.4% | 6,933 | 2.4% | 3,467 | 2.4% | 3,466 | 2.4% | ||
| 51-60 | 333,655 | 21.7% | 310,316 | 22.3% | 23,339 | 16.1% | 46,674 | 16.2% | 23,339 | 16.2% | 23,335 | 16.2% | ||
| 61-70 | 296,163 | 19.3% | 244,247 | 17.6% | 51,916 | 35.8% | 103,798 | 36.0% | 51,905 | 36.0% | 51,893 | 36.0% | ||
| 71-80 | 169,299 | 11.0% | 126,089 | 9.1% | 43,210 | 29.8% | 85,292 | 29.6% | 42,643 | 29.6% | 42,649 | 29.6% | ||
| ≥81 | 98,422 | 6.4% | 76,565 | 5.5% | 21,857 | 15.1% | 43,228 | 15.0% | 21,609 | 15.0% | 21,619 | 15.0% | ||
| Gender | ||||||||||||||
| Female | 1,109,599 | 72.2% | 976,214 | 70.2% | 133,385 | 91.9% | <0.001 | 265,123 | 91.9% | 132,553 | 91.9% | 132,570 | 91.9% | 0.91 |
| Male | 426,449 | 27.8% | 414,725 | 29.8% | 11,724 | 8.1% | 23,441 | 8.1% | 11,729 | 8.1% | 11,712 | 8.1% | ||
| Region | ||||||||||||||
| Midwest | 335,508 | 21.8% | 309,597 | 22.3% | 25,911 | 17.9% | <0.001 | 51,754 | 17.9% | 25,877 | 17.9% | 25,877 | 17.9% | 1.00 |
| Northeast | 383,023 | 24.9% | 347,944 | 25.0% | 35,079 | 24.2% | 70,010 | 24.3% | 35,005 | 24.3% | 35,005 | 24.3% | ||
| South | 596,029 | 38.8% | 540,382 | 38.9% | 55,647 | 38.3% | 110,518 | 38.3% | 55,259 | 38.3% | 55,259 | 38.3% | ||
| West | 221,488 | 14.4% | 193,016 | 13.9% | 28,472 | 19.6% | 56,282 | 19.5% | 28,141 | 19.5% | 28,141 | 19.5% | ||
| Insurance | ||||||||||||||
| Commercial | 707,676 | 46.1% | 664,625 | 47.8% | 43,051 | 29.7% | <0.001 | 86,053 | 29.8% | 43,023 | 29.8% | 43,030 | 29.8% | 1.00 |
| Dual | 54,840 | 3.6% | 43,171 | 3.1% | 11,669 | 8.0% | 22,384 | 7.8% | 11,193 | 7.8% | 11,191 | 7.8% | ||
| Medicaid | 486,451 | 31.7% | 457,656 | 32.9% | 28,795 | 19.8% | 56,959 | 19.7% | 28,479 | 19.7% | 28,480 | 19.7% | ||
| Medicare | 287,081 | 18.7% | 225,487 | 16.2% | 61,594 | 42.4% | 123,168 | 42.7% | 61,587 | 42.7% | 61,581 | 42.7% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 605,264 | 39.4% | 553,886 | 39.8% | 51,378 | 35.4% | <0.001 | 102,148 | 35.4% | 51,064 | 35.4% | 51,084 | 35.4% | 0.94 |
| Yes | 930,784 | 60.6% | 837,053 | 60.2% | 93,731 | 64.6% | 186,416 | 64.6% | 93,218 | 64.6% | 93,198 | 64.6% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.87 | 1.60 | 0.84 | 1.58 | 1.09 | 1.81 | <0.001 | 1.09 | 1.79 | 1.08 | 1.78 | 1.09 | 1.79 | 0.56 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.